Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Cervix Diseases

medroxyprogesterone acetate has been researched along with Cervix Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baras, AS; Darracott, MM; Martirosian, TE; Smith, SC1
Blumenthal, PD; Bright, P; Gaydos, CA; Kwok, C; Morrison, CS; Tucker, HT; Wong, EL; Yacobson, I1
MacLean, R1
Warner, P1
Denny, L; Kuhn, L; Pollack, AE; Wright, TC1
Farmer, M; Gaydos, C; Graham, NM; Jacobson, DL; Peralta, L; Zenilman, J1

Other Studies

6 other study(ies) available for medroxyprogesterone acetate and Cervix Diseases

ArticleYear
Depot medroxyprogesterone acetate: a risk factor for cervical stenosis after loop electrosurgical excisional procedure management of cervical intraepithelial neoplasia?
    Journal of lower genital tract disease, 2010, Volume: 14, Issue:1

    Topics: Adult; Constriction, Pathologic; Contraceptive Agents, Female; Delayed-Action Preparations; Electrosurgery; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postoperative Complications; Risk Factors; Uterine Cervical Diseases; Uterine Cervical Dysplasia; Young Adult

2010
Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections.
    Sexually transmitted diseases, 2004, Volume: 31, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Baltimore; Cervix Uteri; Cohort Studies; Contraception; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Prospective Studies; Risk Factors; Sexually Transmitted Diseases; Uterine Cervical Diseases

2004
Injectable use may increase women's odds of getting chlamydia or gonorrhea.
    International family planning perspectives, 2005, Volume: 31, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Baltimore; Cervix Uteri; Chlamydia Infections; Contraception; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Gonorrhea; Humans; Medroxyprogesterone Acetate; Risk Factors; Sexually Transmitted Diseases; Uterine Cervical Diseases

2005
Concerns regarding design, analysis, and interpretation of the morrison study on hormonal contraceptive use and acquisition of cervical infections.
    Sexually transmitted diseases, 2005, Volume: 32, Issue:10

    Topics: Confounding Factors, Epidemiologic; Contraceptive Agents, Female; Delayed-Action Preparations; Epidemiologic Studies; Female; Humans; Medroxyprogesterone Acetate; Research Design; Sexually Transmitted Diseases; Uterine Cervical Diseases

2005
Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera.
    Contraception, 1999, Volume: 59, Issue:6

    Topics: Adult; Aged; Aging; Atrophy; Cervix Uteri; Contraceptive Agents, Female; Epithelium; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Odds Ratio; Parity; South Africa; Ulcer; Uterine Cervical Diseases; Uterine Cervicitis

1999
Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents.
    Sexually transmitted diseases, 2000, Volume: 27, Issue:6

    Topics: Adolescent; Adolescent Behavior; Adult; Baltimore; Cervix Uteri; Child; Chlamydia Infections; Chlamydia trachomatis; Contraceptives, Oral, Combined; Cross-Sectional Studies; Female; Humans; Medroxyprogesterone Acetate; Multivariate Analysis; Prevalence; Risk Factors; Surveys and Questionnaires; Uterine Cervical Diseases

2000